Gsa Capital Partners LLP Immunic, Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Immunic, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 115,942 shares of IMUX stock, worth $106,666. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,942
Previous 32,766
253.85%
Holding current value
$106,666
Previous $54,000
114.81%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMUX
# of Institutions
77Shares Held
51.2MCall Options Held
824KPut Options Held
354K-
Bvf Inc San Francisco, CA8.9MShares$8.19 Million0.33% of portfolio
-
Avidity Partners Management LP Dallas, TX7.97MShares$7.33 Million0.9% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.71 Million0.51% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$4.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$3.61 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $28.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...